Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.28 | N/A |
| PEG Ratio (TTM) | 0.01 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | -31.09 | N/A |
| P/FCF Ratio (TTM) | -9,396.98 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.41 | N/A |
| Price to 5YR AVG FCF Ratio | -0.73 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | N/A |
| ROE (TTM) | 950.12% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | 6.59% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 49.34% | 88.06% | 72.08% |
| Revenue | N/A | 98.70% | 39.22% |
| Net Income | -2.19% | 412.27% | 87,452.82% |
| Cash Flow | 375.85% | 2,266.96% | 30,633.21% |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.49 | N/A |
| Quick Ratio (TTM) | 0.49 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 39,183.23% | N/A |